Trading the S&P500: what options products are available

Trading the S&P500: what options products are available

Koen Hoorelbeke

Investment and Options Strategist

Summary:  Explore the diverse range of products to trade the S&P 500, understand their nuances, and make informed decisions tailored to your capital, strategy, and risk tolerance.


Trading the S&P 500: different option products


Introduction to the S&P 500


The S&P 500, also known as the Standard & Poor's 500, is one of the most widely followed equity indices in the world. Representing the stock performance of 500 large companies listed on U.S. stock exchanges, the S&P 500 serves as a key indicator of the health of the U.S. stock market and the broader economy.

It's important to note that the S&P 500 index itself is not directly tradable. An index is essentially a calculation, representing a snapshot of the market it covers, and thus, there's nothing tangible to deliver. This is why derivatives like options exist, allowing traders and investors to gain exposure and trade indirectly based on the performance of the S&P 500 index.

Guiding questions for choosing the right S&P 500 product


Before diving into the specifics of each product, consider these guiding questions to determine which S&P 500 product best aligns with your trading goals and resources:

- What is your available capital?
  - Different products have varying contract sizes, which can align better or worse with your capital.
 
- How important is liquidity to you?
  - Tight bid-ask spreads and the ability to easily enter or exit positions can be crucial for frequent trading.
 
- Are you comfortable with the risk of early assignment?
  - European style options, like SPX and XSP, eliminate this risk, while American style options, like SPY, carry it.
 
- How significant are margin requirements in your trading plan?
  - Some strategies and products require more capital than others. Defined risk strategies tend to require less margin than undefined risk strategies.
 
- Do you trade during non-standard hours?
  - Some products offer extended trading hours, beneficial for certain strategies or international traders.
 

Comparative analysis of S&P 500 products


1.
SPX options:
  • Ticker:
    spx:xcbf
  • Contract size:
    100 * index
  • Pros:
    - Direct exposure to the index.
    - European style, eliminating early assignment risk.
    - Suitable for larger portfolios due to its size.
    - Cash settlement simplifies the expiration process.
    - Divers expiry options including weekly/daily expirations.
  • Cons:
    - Higher capital requirement.
    - Might be too large for retail traders.
    - No dividends
2. XSP options:
  • Ticker:
    xsp:xcbf
  • Contract size:
    10 * index
  • Pros:
    - Offers a smaller contract size, more accessible for retail investors.
    - European style, eliminating early assignment risk.
    - Cash settlement simplifies the expiration process.
    - Diverse expiry options including weekly/daily expirations.
  • Cons:
    - Less liquidity compared to SPX.
    - No dividends
3. SPY options:
  • Ticker:
    spy:xcbf
  • Contract size:
    100 * spy (spy is approx. equal to xsp-index)
  • Pros:
    - Extremely liquid, very tight bid-ask spreads
    - American style allows for more strategy flexibility.
    - Aligns closely with the index's performance.
    - Deliverable (meaning you can buy and own them)
  • Cons:
    - Early assignment risk due to American style.
4. ES (S&P 500 futures options):
  • Ticker:
    esw3:xcme
  • Contract size:
    50 * index
  • Pros:
    - Offers leverage.
    - Aligns closely with the index.
    - American style.
  • Cons:
    - Higher capital requirement.
    - Early assignment risk.
5. MES (S&P 500 micro futures options):
  • Ticker:
    mes:xcme
  • Contract size:
    5 * index
  • Pros:
    - Smallest contract size, accessible for all levels of traders.
  • Cons:
    - Less liquidity than its larger counterparts.
 

Using the above information we can have a look at a few scenarios in which a fictional character makes a choice on how he/she will trade the S&P500 index.

Scenario 1:
Mike is an experienced trader with a capital of $25,000. He has a keen interest in trading volatility on the S&P 500 and prefers using advanced strategies like iron condors and broken wing butterflies. Here's how he might approach his decision:

Determine Exposure and Risk Tolerance:
With his capital, Mike has to be cautious about the products he chooses. Trading SPX directly might be capital-intensive, especially with complex and/or undefined strategies

Selecting the Product:
Given his capital and preference for advanced strategies, Mike might lean towards XSP or SPY. Both products offer a smaller contract size, aligning better with his account size. XSP might also be the better choice if Mike will trade strategies that might have legs In-The-Money, which are susceptable to early assignments.

Scenario 2:
Jane is a trader with a capital of $100,000. She believes that the S&P 500 will decline in the next month and wants to make a bearish trade. Here's how she might approach her decision:

Determine Exposure and Risk Tolerance:
With her capital, Jane can afford to trade any of the S&P 500 products. However, she must decide how much of her capital she wants to risk. If she's only willing to risk a small percentage, she might gravitate towards a product with a smaller nominal value, like XSP or MES.

Selecting the Product:
Jane wants direct exposure to the index, so she leans towards SPX or XSP. Given her capital, she can handle the larger contract size of SPX.

Consider Margin Requirements:
If Jane decides to sell a call option, she needs to ensure she has sufficient margin. With her capital, she can handle the margin requirements of the SPX, but she must be cautious not to over-leverage herself.
 

Final thoughts

The S&P 500 is a significant market benchmark, and the range of products available for trading it offers flexibility to different types of traders. Whether you have a large capital base and seek direct exposure to the index or operate with a smaller account looking for more intricate strategies, there's an S&P 500 product tailored for you.
 
Always remember, the right product isn't just about potential profits, but aligning with your risk tolerance, trading goals, and strategies. While the array of choices might seem daunting, taking the time to reflect on your needs and understanding the nuances of each product will lead you to make informed decisions.

Options are complex, high-risk products and require knowledge, investment experience and, in many applications, high risk acceptance. We recommend that before you invest in options, you inform yourself well about the operation and risks. In Saxo Bank's Terms of Use you will find more information on this in the Important Information Options, Futures, Margin and Deficit Procedure. You can also consult the Essential Information Document of the option you want to invest in on Saxo Bank's website.

Quarterly Outlook

01 /

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Chief Macro Strategist

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Chief Macro Strategist

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

  • Equity Outlook: Will lower rates lift all boats in equities?

    Quarterly Outlook

    Equity Outlook: Will lower rates lift all boats in equities?

    Peter Garnry

    Chief Investment Strategist

    After a period of historically high equity index concentration driven by the 'Magnificent Seven' sto...
  • Commodity Outlook: Gold and silver continue to shine bright

    Quarterly Outlook

    Commodity Outlook: Gold and silver continue to shine bright

    Ole Hansen

    Head of Commodity Strategy

  • Macro Outlook: The US rate cut cycle has begun

    Quarterly Outlook

    Macro Outlook: The US rate cut cycle has begun

    Peter Garnry

    Chief Investment Strategist

    The Fed started the US rate cut cycle in Q3 and in this macro outlook we will explore how the rate c...
  • FX Outlook: USD in limbo amid political and policy jitters

    Quarterly Outlook

    FX Outlook: USD in limbo amid political and policy jitters

    Charu Chanana

    Chief Investment Strategist

    As we enter the final quarter of 2024, currency markets are set for heightened turbulence due to US ...
Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.